Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years
Mauro Maccarrone
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
Kinga Tóth, Dorottya Ádám, Tamás Bı́ró, et al.
Molecules (2019) Vol. 24, Iss. 5, pp. 918-918
Open Access | Times Cited: 176
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
Christopher A. Legare, Wesley M. Raup‐Konsavage, Kent E. Vrana
Pharmacology (2022) Vol. 107, Iss. 3-4, pp. 131-149
Open Access | Times Cited: 172
Effects of Exercise Training on the Autonomic Nervous System with a Focus on Anti-Inflammatory and Antioxidants Effects
Matei Daniela, Cătălina Luca, Ilie Onu, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 350-350
Open Access | Times Cited: 132
Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
Elliot D. Mock, Berend Gagestein, Mario van der Stelt
Progress in Lipid Research (2022) Vol. 89, pp. 101194-101194
Open Access | Times Cited: 85
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Beyond THC and Endocannabinoids
Pál Pacher, Natalya M. Kogan, Raphael Mechoulam
The Annual Review of Pharmacology and Toxicology (2019) Vol. 60, Iss. 1, pp. 637-659
Closed Access | Times Cited: 143
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh, Zoltán Szekanecz, Tamás Bı́ró
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118
A Guide to Targeting the Endocannabinoid System in Drug Design
Adam Stasiulewicz, Katarzyna Znajdek, Monika Grudzień, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2778-2778
Open Access | Times Cited: 102
Cannabinoid Regulation of Fear and Anxiety: an Update
Eleni P. Papagianni, Carl W. Stevenson
Current Psychiatry Reports (2019) Vol. 21, Iss. 6
Open Access | Times Cited: 94
Brain activity of anandamide: a rewarding bliss?
María Scherma, Paolo Masia, Valentina Satta, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 309-323
Open Access | Times Cited: 86
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
Noëlle van Egmond, Verena M. Straub, Mario van der Stelt
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 441-463
Open Access | Times Cited: 80
The Epigenetics of the Endocannabinoid System
Rosaria Meccariello, Antonietta Santoro, Stefania D’Angelo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1113-1113
Open Access | Times Cited: 71
Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
A.M. Martins, Ana Luísa Gomes, Inês Vilas Boas, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 210-210
Open Access | Times Cited: 53
Cannabidiol (CBD) in Cancer Management
Kylie O’Brien
Cancers (2022) Vol. 14, Iss. 4, pp. 885-885
Open Access | Times Cited: 49
Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions
Ana Tadijan, Ignacija Vlašić, Josipa Vlainić, et al.
Antioxidants (2022) Vol. 11, Iss. 10, pp. 2049-2049
Open Access | Times Cited: 38
Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice
Elliot D. Mock, Mohammed Ahmed Mustafa, Ozge Gunduz‐Cinar, et al.
Nature Chemical Biology (2020) Vol. 16, Iss. 6, pp. 667-675
Open Access | Times Cited: 69
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors
Siyu Ren, Zhen‐Zhen Wang, Yi Zhang, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 10, pp. 1263-1271
Open Access | Times Cited: 66
Effects of cannabis tetrahydrocannabinol on endocannabinoid homeostasis in human placenta
J. Costa Maia, Luís Midão, Sara C. Cunha, et al.
Archives of Toxicology (2019) Vol. 93, Iss. 3, pp. 649-658
Open Access | Times Cited: 55
Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
Farjana Afrin, Mengna Chi, Andrew L. Eamens, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 1033-1033
Open Access | Times Cited: 55
Roles of Endocannabinoids and Endocannabinoid-Like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective
S.M. Khaledur Rahman, Toru Uyama, Zahir Hussain, et al.
Annual Review of Nutrition (2021) Vol. 41, Iss. 1, pp. 177-202
Closed Access | Times Cited: 49
The Interplay between the Immune and the Endocannabinoid Systems in Cancer
Mariantonia Braile, Simone Marcella, Gianni Marone, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1282-1282
Open Access | Times Cited: 42
Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia
Gerwyn Morris, Luba Sominsky, Kenneth R. Walder, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3485-3503
Closed Access | Times Cited: 30
Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses
Tina Zimmermann, Julia Bartsch, Annika Beer, et al.
Neuropsychopharmacology (2018) Vol. 44, Iss. 8, pp. 1377-1388
Open Access | Times Cited: 57
Anandamide Revisited: How Cholesterol and Ceramides Control Receptor-Dependent and Receptor-Independent Signal Transmission Pathways of a Lipid Neurotransmitter
Coralie Di Scala, Jacques Fantini, Nouara Yahi, et al.
Biomolecules (2018) Vol. 8, Iss. 2, pp. 31-31
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top